why choose us

First received: July 28, 2023

Clinical Trial: Individualized Treatments in Adults With Relapsed/Refractory Cancers

Study Status: Completed

Recruit Status: RECRUITING

Condition: Refractory Cancer

Study Type: INTERVENTIONAL


Official Title: Individualized Treatments in Adults With Relapsed/Refractory Cancers

Brief Summary: A personalized cancer medicine approach would address therapy resistance, cancer metastasis, and limited options after standard of care is exhausted in advanced cancer participants.This approach may reduce the barriers to approved therapeutic assignment currently limited to a particular cancer type or patient demographic.

Read more